Scott M. Myers, MBA

PearlDiver Technologies

Poster(s):

• (183) Impact of COVID-19 on non-COVID related treatment patterns and outcomes in patients with inflammatory bowel disease (IBD)
  Wednesday, October 29, 2025

• (198) Comparative outcomes for transgender patients: Gaps in HIV pre-exposure prophylaxis (PrEP) adoption between transgender and cisgender individuals.
  Wednesday, October 29, 2025

• (344) Disruption and adaptation in inflammatory bowel disease: Impact of the COVID-19 pandemic on treatment patterns, healthcare utilization, and vaccination in the United States
  Wednesday, October 29, 2025